Literature DB >> 6023850

Effect of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones.

S N Gershoff, E L Prien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6023850     DOI： 10.1093/ajcn/20.5.393

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN： 0002-9165            Impact factor:   7.045


× No keyword cloud information.
  9 in total

1.  Initiation and inhibition of subcutaneous calcification.

Authors:  F Leonard; J W Boke; R J Ruderman; A F Hegyeli
Journal:  Calcif Tissue Res       Date:  1972

Review 2.  Oxalic acid metabolism in man: a review.

Authors:  A Hodgkinson; P M Zarembski
Journal:  Calcif Tissue Res       Date:  1968-10-21

3.  Management of urinary calculi: updated.

Authors:  Y Taguchi
Journal:  Can Med Assoc J       Date:  1970-01-31       Impact factor: 8.262

4.  Treatment of primary hyperoxaluria.

Authors:  C E Dent; T C Stamp
Journal:  Arch Dis Child       Date:  1970-12       Impact factor: 3.791

5.  Deposition of calcium oxalate in the skin in two patients suffering from oxalosis caused by primary hyperoxaluria.

Authors:  L H Jansen; J L Groeneveld; J B Van Der Meer
Journal:  Arch Dermatol Forsch       Date:  1974

6.  Pyridoxine-related metabolite concentrations in normal and Down syndrome amniotic fluid.

Authors:  Paddy Jim Baggot; Anna Jane Y Eliseo; Nathaniel G DeNicola; Jeremy A Kalamarides; James D Shoemaker
Journal:  Fetal Diagn Ther       Date:  2008-04-14       Impact factor: 2.587

7.  Stone incidence as related to water hardness in different geographical regions of the United States.

Authors:  R Sierakowski; B Finlayson; R Landes
Journal:  Urol Res       Date:  1979-09

8.  Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria.

Authors:  Agnes Kaelin; Jean-Paul Casez; Philippe Jaeger
Journal:  Urol Res       Date:  2003-11-20

9.  In female rats, ethylene glycol treatment elevates protein expression of hepatic and renal oxalate transporter sat-1 (Slc26a1) without inducing hyperoxaluria.

Authors:  Davorka Breljak; Hrvoje Brzica; Ivana Vrhovac; Vedran Micek; Dean Karaica; Marija Ljubojević; Ankica Sekovanić; Jasna Jurasović; Dubravka Rašić; Maja Peraica; Mila Lovrić; Nina Schnedler; Maja Henjakovic; Waja Wegner; Gerhard Burckhardt; Birgitta C Burckhardt; Ivan Sabolić
Journal:  Croat Med J       Date:  2015-10       Impact factor: 1.351
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.